The Kidney Disease:Improving Global Outcomes(KDIGO)2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease(CKD)represents the first KDIGO guideline on this subject.The scope includes topics such as comprehensive care,glycemic monitoring and targets,lifestyle and antihyperglycemic interventions,and approaches to self-management and optimal models of care.The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations with infographics based on a rigorous,formal systematic literature review.Another aim is to propose research recommendations for areas in which there are gaps in knowledge.The guideline targets a broad audience of clinicians treating diabetes and CKD while taking into account implications for policy and payment.The development of this guideline followed an explicit process of evidence review and appraisal.Treatment approaches and guideline recommendations are based on systematic reviews of relevant studies,appraisal of the quality of the evidence,and the strength of recommendations following the Grading of Recommendations Assessment,Development,and Evaluation(GRADE)approach.Limitations of the evidence are discussed and areas for future research are presented.

肾病：改善全球预后 (KDIGO)2020 年慢性肾病 (CKD) 糖尿病管理临床实践指南代表了 KDIGO 关于这一主题的第一个指南。范围包括综合护理、血糖监测和目标、生活方式和抗高血糖干预、自我管理方法和最佳护理模式等主题。该指南的目标是通过提供基于严格、正式的系统文献综述的信息图表可操作的建议，为临床医生和患者提供有用的资源。另一个目的是针对知识存在差距的领域提出研究建议。该指南针对治疗糖尿病和 CKD 的临床医生的广泛受众，同时考虑到对政策和建议的影响。该指南的制定遵循了明确的证据审查和评估过程。治疗方法和指南建议是基于对相关研究的系统审查、证据质量的评估以及遵循建议的强度。和评价 (GRADE) 方法。讨论了证据的局限性，并介绍了未来研究的领域。